2026-01-15 - Analysis Report
# Financial Report: Planet Labs PBC (PL) Analysis

## Company Overview
Planet Labs PBC (PL) is a space technology company.

## Return Rate Comparison
- Cumulative return of review stock (PL): 454.14%
- Cumulative return of comparison stock (S&P 500, VOO): 41.64%
- The degree of divergence: 412.50 (absolute), 100.00% (relative)
- **Divergence analysis**: The review stock (PL) has a much higher cumulative return rate compared to the comparison stock (VOO), indicating a significant divergence.

## Alpha, Beta Analysis
| Year | CAGR | MDD | Alpha | Beta | Cap(B) |
|------|------|------|-------|------|-------|
| 2022-2024 | 8.0% | 45.2% | -12.0% | 1.8 | 1.3B |
| 2023-2025 | 334.0% | 51.0% | 272.0% | 2.2 | 6.2B |

## Stock Price Fluctuation Analysis
| Metric | Value |
|--------|-------|
| Close | $26.73 |
| 5-day SMA | $24.53 |
| 20-day SMA | $21.01 |
| 60-day SMA | $15.57 |
- **Recent stock price fluctuation**: The stock price has fluctuated significantly, with a recent sharp rebound from $25.32 to $26.73.

## RSI, PPO Index Indicators
- Market Risk Indicator (MRI): 0.70
- RSI: 81.19
- PPO: 1.14
- Hybrid Signal: Buy
- Recent (20 days) relative divergence change: 0.00
- 7-day Rank change: 0
- 7-day Dynamic Expected Return change: 0.00
- **Expected Return**: -5.90%
- **Risk Level**: Medium

## News & Significant Events
- Recent news articles suggest positive sentiment towards the company, with a 9-figure deal with Sweden and expected stock price rise.

## Analyst Opinions
- Analyst Consensus:
  - Key: Buy
  - Mean (1=StrongBuy~5=Sell): 1.70 (~Buy)
  - Opinions: 9
  - Target Price (avg/high/low): 23.70 / 30.00 / 12.30

## Recent Earnings Analysis

| Date | EPS | Revenue |
|----|---:|---:|
| 2025-10-28 | 0.82 | 2.21 B$ |
| 2025-07-30 | 0.61 | 2.18 B$ |
| 2025-04-29 | 0.64 | 2.14 B$ |
| 2025-02-14 | 1.38 | 2.20 B$ |
| 2024-10-25 | 1.08 | 2.04 B$ |

## Financial Information

### Revenue and Profitability

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-10-31 | $0.08B | 57.33% |
| 2025-07-31 | $0.07B | 57.60% |
| 2025-04-30 | $0.07B | 55.24% |
| 2025-01-31 | $0.06B | 62.08% |
| 2024-10-31 | $0.06B | 61.24% |

### Capital and Profitability

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-10-31 | $0.35B | -16.93% |
| 2025-07-31 | $0.44B | -5.19% |
| 2025-04-30 | $0.44B | -2.84% |
| 2025-01-31 | $0.44B | -7.97% |
| 2024-10-31 | $0.46B | -4.32% |

## Comprehensive Analysis (Summary of previous items)
The review stock (PL) has exhibited significant fluctuations in stock price, with a recent sharp rebound. The return rate comparison with the S&P 500 (VOO) suggests a substantial divergence, with a 100.00% relative divergence. The Alpha, Beta analysis indicates a relatively stable performance with high growth potential. RSI, PPO index indicators suggest a buy signal, and the market risk indicator is at a medium level. Analyst opinions are positive with a mean rating of 1.70 (~Buy). The expected return is -5.90%, and the recent earnings analysis shows mixed results, with increasing revenue but decreasing profit margins.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.